Best Stocks Under $3 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. atai Life Sciences NASDAQ:ATAI$2.70 +0.05 (+1.89%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.67 -0.03 (-1.11%) As of 06:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life SciencesMarket Capitalization$530.90 millionP/E Ratio-2.97Consensus RatingStrong BuyConsensus Price Target$9.00 (+233.3% Upside)Volume2.24 million sharesAverage Volume2.10 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. OS Therapies NYSE:OSTX$1.68 +0.10 (+6.33%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.66 -0.02 (-1.19%) As of 05:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS TherapiesMarket Capitalization$47.21 millionP/E Ratio-1.95Consensus RatingBuyConsensus Price Target$18.00 (+971.4% Upside)Volume294,519 sharesAverage Volume487,619 shares3. zSpace NASDAQ:ZSPC$2.68 -0.05 (-1.83%) As of 07/16/2025 04:00 PM EasternzSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpaceMarket Capitalization$62.47 millionConsensus RatingBuyConsensus Price Target$15.00 (+459.7% Upside)Volume83,666 sharesAverage Volume56,705 sharesToday's Range$2.55▼$2.784. TuHURA Biosciences NASDAQ:HURA$2.36 +0.06 (+2.61%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.33 -0.03 (-1.10%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA BiosciencesMarket Capitalization$100.46 millionConsensus RatingBuyConsensus Price Target$12.67 (+436.7% Upside)Volume228,966 sharesAverage Volume260,254 sharesToday's Range$2.23▼$2.385. Western Copper & Gold NYSE:WRN$1.25 -0.03 (-2.34%) As of 07/16/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$250.29 millionP/E Ratio-62.50Consensus RatingBuyConsensus Price Target$4.00 (+220.0% Upside)Volume299,460 sharesAverage Volume373,918 shares6. OnKure Therapeutics NASDAQ:OKUR$2.49 -0.02 (-0.80%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.50 +0.01 (+0.40%) As of 07/16/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure TherapeuticsMarket Capitalization$33.91 millionP/E Ratio-0.47Consensus RatingBuyConsensus Price Target$32.33 (+1,198.5% Upside)Volume162,350 sharesAverage Volume106,841 shares7. Denison Mine NYSEAMERICAN:DNN$2.03 +0.16 (+8.56%) Closing price 07/16/2025 04:10 PM EasternExtended Trading$2.00 -0.03 (-1.72%) As of 06:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MineMarket Capitalization$1.68 billionP/E Ratio-25.38Consensus RatingBuyConsensus Price Target$3.00 (+47.8% Upside)Volume116.62 million sharesAverage Volume51.93 million shares8. Quince Therapeutics NASDAQ:QNCX$1.68 -0.05 (-2.89%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.62 -0.06 (-3.57%) As of 05:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$78.66 millionP/E Ratio-1.21Consensus RatingBuyConsensus Price Target$8.00 (+376.2% Upside)Volume243,051 sharesAverage Volume313,375 shares9. Immunic NASDAQ:IMUX$0.90 +0.06 (+7.53%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.85 -0.04 (-4.67%) As of 06:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$79.83 millionP/E Ratio-0.73Consensus RatingBuyConsensus Price Target$7.50 (+737.2% Upside)Volume778,118 sharesAverage Volume975,818 shares10. Reviva Pharmaceuticals NASDAQ:RVPH$0.38 -0.01 (-1.49%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.39 +0.00 (+1.09%) As of 05:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$18.70 millionP/E Ratio-0.49Consensus RatingBuyConsensus Price Target$9.00 (+2,245.0% Upside)Volume1.94 million sharesAverage Volume1.44 million shares11. Rezolve AI NASDAQ:RZLV$2.65 +0.22 (+9.05%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.84 +0.20 (+7.36%) As of 06:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$506.07 millionConsensus RatingBuyConsensus Price Target$6.00 (+126.4% Upside)Volume7.23 million sharesAverage Volume5.63 million sharesToday's Range$2.41▼$2.6612. Nuvation Bio NYSE:NUVB$2.24 +0.12 (+5.40%) Closing price 07/16/2025 03:59 PM EasternExtended Trading$2.26 +0.02 (+0.89%) As of 05:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation BioMarket Capitalization$724.76 millionP/E Ratio-0.96Consensus RatingBuyConsensus Price Target$7.17 (+219.2% Upside)Volume4.21 million sharesAverage Volume3.09 million shares13. HIVE Digital Technologies NASDAQ:HIVE$2.20 +0.04 (+1.85%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.17 -0.03 (-1.14%) As of 06:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital TechnologiesMarket Capitalization$462.90 millionP/E Ratio-6.11Consensus RatingBuyConsensus Price Target$6.57 (+198.7% Upside)Volume37.65 million sharesAverage Volume9.48 million shares14. Ceragon Networks NASDAQ:CRNT$2.39 +0.03 (+1.27%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.41 +0.02 (+0.79%) As of 06:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. More about Ceragon NetworksMarket Capitalization$209.87 millionP/E Ratio9.19Consensus RatingBuyConsensus Price Target$6.00 (+151.0% Upside)Volume832,209 sharesAverage Volume1.13 million shares15. Mereo BioPharma Group NASDAQ:MREO$1.75 +0.04 (+2.34%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.77 +0.02 (+1.14%) As of 05:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$271.89 millionP/E Ratio-25.00Consensus RatingBuyConsensus Price Target$7.20 (+311.4% Upside)Volume3.26 million sharesAverage Volume1.33 million shares16. ImmunityBio NASDAQ:IBRX$2.75 +0.01 (+0.36%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.77 +0.02 (+0.73%) As of 05:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBioMarket Capitalization$2.42 billionP/E Ratio-4.74Consensus RatingBuyConsensus Price Target$12.25 (+345.5% Upside)Volume6.40 million sharesAverage Volume6.30 million shares17. Lucid Diagnostics NASDAQ:LUCD$1.09 -0.08 (-6.84%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.10 +0.01 (+1.38%) As of 04:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$126.58 millionP/E Ratio-0.81Consensus RatingBuyConsensus Price Target$3.55 (+225.7% Upside)Volume1.81 million sharesAverage Volume699,387 shares18. FibroBiologics NASDAQ:FBLG$0.72 +0.02 (+3.29%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.68 -0.04 (-5.69%) As of 06:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$27.66 millionP/E Ratio-3.43Consensus RatingBuyConsensus Price Target$13.00 (+1,705.6% Upside)Volume439,772 sharesAverage Volume309,271 shares19. GeoVax Labs NASDAQ:GOVX$0.73 +0.04 (+6.43%) As of 07/16/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$10.99 millionP/E Ratio-0.20Consensus RatingBuyConsensus Price Target$8.88 (+1,108.3% Upside)Volume2.53 million sharesAverage Volume3.14 million shares20. Ovid Therapeutics NASDAQ:OVID$0.39 +0.02 (+5.98%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.41 +0.02 (+4.87%) As of 05:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$26.17 millionP/E Ratio-1.11Consensus RatingBuyConsensus Price Target$3.13 (+701.3% Upside)Volume495,126 sharesAverage Volume447,530 shares21. Stardust Power NASDAQ:SDST$0.43 +0.02 (+3.91%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.42 -0.01 (-2.33%) As of 06:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$24.90 millionP/E Ratio-0.58Consensus RatingBuyConsensus Price Target$5.11 (+1,089.0% Upside)Volume7.48 million sharesAverage Volume2.52 million shares22. Biomea Fusion NASDAQ:BMEA$1.91 +0.13 (+7.30%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.90 -0.01 (-0.52%) As of 05:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$66.88 millionP/E Ratio-0.54Consensus RatingBuyConsensus Price Target$20.10 (+952.4% Upside)Volume699,512 sharesAverage Volume1.17 million shares23. Context Therapeutics NASDAQ:CNTX$0.83 +0.09 (+12.23%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$0.84 +0.01 (+1.19%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$65.96 millionP/E Ratio-2.66Consensus RatingBuyConsensus Price Target$5.50 (+566.5% Upside)Volume348,277 sharesAverage Volume274,785 shares24. Gain Therapeutics NASDAQ:GANX$1.62 -0.08 (-4.71%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.64 +0.01 (+0.93%) As of 05:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$50.91 millionP/E Ratio-1.88Consensus RatingBuyConsensus Price Target$8.20 (+406.2% Upside)Volume935,286 sharesAverage Volume296,547 shares25. Zura Bio NASDAQ:ZURA$1.29 -0.01 (-0.77%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.28 -0.01 (-0.39%) As of 05:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. More about Zura BioMarket Capitalization$88.89 millionP/E Ratio-1.84Consensus RatingBuyConsensus Price Target$14.33 (+1,011.1% Upside)Volume178,560 sharesAverage Volume467,141 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Super Micro Stock May Benefit as Cooling Demand Takes Off Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
